Moreover, in lieu of the differential expression of CD41 on platelets of cirrhosis and HCC patients, further confirmatory studies need to be carried out to confirm the hypothesis of its involvement in HCC. This evidence concerns the gene ITGA2B and hepatocellular carcinoma.